NCT00838214View on ClinicalTrials.gov

Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Autoimmune Hepatitis
Interventions
DRUG

budesonide

3mg capsule, 3x per day for 6 months

DRUG

prednisone

5mg tablet, 40mg starting dose per day, titration to 10mg per day within 3 months

Trial Locations (1)

D-30625

Medical School Hannover, Hanover

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY